FDA NDC Directory · JSON-LD · Markdown

Exjade

NDC 0078-0468 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Generic namedeferasirox
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA021882
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsDEFERASIROX (125 mg/1)
Marketing started20051130
Package count1

External sources

Source: openFDA. Public-domain (CC0).